Cardiac thromboxane A2 receptor activation does not directly induce cardiomyocyte hypertrophy but does cause cell death that is prevented with gentamicin and 2-APB

Tekijä Touchberry, Chad D, Silswal, Neerupma, Tchikrizov, Vladimir, Elmore, Christopher J, Srinivas, Shubra, Akthar, Adil S, Swan, Hannah K, Wetmore, Lori A, Wacker, Michael J
Julkaisussa BMC Pharmacol Toxicol (2014)

FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy

Tekijä Touchberry, Chad D., Green, Troy M., Tchikrizov, Vladimir, Mannix, Jaimee E., Mao, Tiffany F., Carney, Brandon W., Girgis, Magdy, Vincent, Robert J., Wetmore, Lori A., Dawn, Buddhadeb, Bonewald, Lynda F., Stubbs, Jason R., Wacker, Michael J.
Julkaistu 2013